Bottom line
What is ERGOX's expense ratio?
ERGOX's expense ratio is 3.01%, or about $301 a year on every $10,000 invested. That is more expensive than 96% of government & Treasury bond funds we track (median 0.5%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Feb 26, 2026
ERGOX fee table
| Net expense ratio | 3.01% |
|---|---|
| Gross expense ratio | 3.1% |
| Management fee | 0.65% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 1.95% |
| Fee waiver / reimbursement | -0.09% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 26, 2026
What ERGOX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| ERGOX | $304 | $948 | $1,618 | $3,405 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 3.01% expense ratio costs roughly $140,500 in lost growth, versus about $28,900 for the median government & Treasury bond fund (0.5%).